Nico Van Hoecke is MSD President for Eastern Europe Middle East and Africa (EEMEA) overseeing the human health business in 70+ countries and close to 1700 staff.
In his position as President, Nico ensures that countries in EEMEA are well equipped and able to offer patients, customers and governments with MSD’s wide range of lifesaving medicines and vaccines. The portfolio of medicines includes an extensive range of off-patent medicines and many of MSD’s newer, innovative medicines and vaccines.
Prior to taking up his post as EEMEA President, Nico led the Finance Organization for MSD’s Emerging Markets, overseeing the financial departments of all countries in Latin America, EEMEA and Asia Pacific.
Nico started his tenure within EEMEA in 2009 as Regional Finance lead for the region. This was followed by two years as Business & Commercial Operations lead for the same region. These two positions together with his experience as Emerging Markets Finance lead have served to help him understand the intricacies of working in a challenging and very rewarding region.
Nico is a Belgian National with a Masters in Corporate Income Taxes and Commercial Sciences, Specialty in Accountancy; and a Bachelor’s Degree in Commercial Sciences all from EHSAL in Brussels.
Prior to joining MSD in 1998, Nico was an External Auditor with Deloitte Touche.